Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts

被引：1
|
作者：
Sanchez-Munoz, Enrique [1 ,2 ]
Requena-Ibanez, Juan Antonio [2 ]
Badimon, Juan Jose [1 ]
机构：
[1] Complejo Asistencial Univ Leon, Serv Cardiol, Leon, Spain
[2] Icahn Sch Med Mt Sinai, Mt Sinai Fuster Heart Hosp, Atherothrombosis Res Unit, New York, NY 10029 USA
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2024年 / 77卷 / 07期
关键词：
D O I：
10.1016/j.rec.2024.01.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：510 / 514
页数：5
相关论文
共 50 条
  • [31] Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus
    Cui, Haigang
    Luo, Xin
    Chen, Mingwei
    Lu, Jun
    Liu, Johnson J. J.
    CURRENT DRUG TARGETS, 2023, 24 (08) : 648 - 661
  • [32] LX4211, a dual inhibitor of SGLT1 and SGLT2, results in postprandial glucose reductions in healthy subjects
    Lapuerta, P.
    Ogbaa, I.
    Powell, D.
    Banks, P.
    Turnage, A.
    Frazier, K.
    Boehm, K. A.
    Freiman, J.
    Ruff, D.
    Sands, A.
    Zambrowicz, B.
    DIABETOLOGIA, 2012, 55 : S319 - S319
  • [33] Discovery and development of LX4211, a dual inhibitor of SGLT1 and SGLT2 for the treatment of type 2 diabetes mellitus
    Rawlins, David B.
    Frazier, Kenny S.
    Freiman, Joel
    Goodwin, Nicole C.
    Harrison, Bryce A.
    Healy, Jason
    Mabon, Ross
    Powell, David R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [34] SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study
    Lv, Yanchen
    Cheng, Xin
    Dong, Qiang
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [35] LX4211, a Dual Inhibitor of SGLT1 and SGLT2, Results in Postprandial Glucose Reductions in Healthy Subjects
    Ogbaa, Ike
    Powell, David
    Banks, Phillip
    Turnage, Anne
    Frazier, Kenny
    Boehm, Kristi A.
    Freiman, Joel
    Sands, Arthur
    Zambrowicz, Brian
    DIABETES, 2012, 61 : A293 - A293
  • [36] More than apical: distribution of SGLT1 in Caco-2 cells
    Kipp, H
    Khoursandi, S
    Scharlau, D
    Kinne, RKH
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (04): : C737 - C749
  • [37] SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats
    Naoki Oshima
    Hiroshi Onimaru
    Aoi Yamashiro
    Hiroyasu Goto
    Keiko Tanoue
    Tsugumi Fukunaga
    Hiroki Sato
    Asuka Uto
    Hidehito Matsubara
    Toshihiko Imakiire
    Hiroo Kumagai
    Hypertension Research, 2024, 47 : 46 - 54
  • [38] Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1
    Sayour, Alex Ali
    Ruppert, Mihaly
    Olah, Attila
    Benke, Kalman
    Barta, Balint Andras
    Zsary, Eszter
    Merkely, Bela
    Radovits, Tamas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [39] SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats
    Oshima, Naoki
    Onimaru, Hiroshi
    Yamashiro, Aoi
    Goto, Hiroyasu
    Tanoue, Keiko
    Fukunaga, Tsugumi
    Sato, Hiroki
    Uto, Asuka
    Matsubara, Hidehito
    Imakiire, Toshihiko
    Kumagai, Hiroo
    HYPERTENSION RESEARCH, 2024, 47 (01) : 46 - 54
  • [40] SGLT1 inhibition: Pros and cons
    Tsimihodimos, Vasilis
    Filippas-Ntekouan, Sebastien
    Elisaf, Moses
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838 : 153 - 156
12345